Crossmark

Italian Expert Consensus on the Efficacy and Safety of High Doses of Incobotulinum Toxin A (Bocouture®) in a Full-Face Approach Based on the Electromyographic Analysis

Crossref DOI link: https://doi.org/10.1007/s13555-025-01632-7

Published Online: 2026-03-30

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fundarò, Salvatore Piero https://orcid.org/0000-0002-8152-197X
Lozza, Alessandro

Muti, Gabriele Ferruccio

Renzi, Massimo

Santoro, Stefano

Zerbinati, Nicola
Funding

Funding for this research was provided by:

Merz Aesthetics Italia Srl
License Information

Text and Data Mining valid from 2026-03-30

Version of Record valid from 2026-03-30
More Information

Article History

Received: 12 August 2025

Accepted: 12 December 2025

First Online: 30 March 2026

Declarations

:

: Salvatore Piero Fundarò has received consultancy and speaker honoraria from Evolus Pharma B.V., IBSA Italy, Merz Aesthetics Italia Srl, and Relife Srl. Alessandro Lozza has received honoraria for scientific consultancy and training activities from Merz Aesthetics Italia Srl and Spes Medica Spa. Massimo Renzi and Nicola Zerbinati has received scientific consultancy honoraria from Merz Aesthetics Italia Srl. Gabriele Ferruccio Muti and Stefano Santoro declare that they have no competing interests.

: All procedures involving healthy volunteers were conducted in accordance with Good Clinical Practice guidelines. Written informed consent was obtained from all individuals for participation, data collection, and publication of images and videos.

Document is current

Any future updates will be listed below